Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2018
Pharmaceutical pricing conundrum: time to get rid of it?
21 October 2018 - A basic concept of economics is that a price stems from the intersection between supply and demand ...
Posted by Michael Wonder on 20 Oct 2018
Is the EUnetHTA HTA core model fit for purpose? Evaluation from an industry perspective
18 October 2018 - The HTA Core Model was developed to improve the transferability of health technology assessment between settings. ...
Posted by Michael Wonder on 20 Oct 2018
Cost, context, and decisions in health economics and health technology assessment
18 October 2018 - This study is an attempt to demystify and clarify the idea of cost in health economics ...
Posted by Michael Wonder on 20 Oct 2018
Some European countries decide to cover cancer drugs much faster than others
19 October 2018 - Some European countries take more than twice as long as others to decide whether to provide ...
Posted by Michael Wonder on 19 Oct 2018
Competition watchdog’s appeal over Pfizer ruling dismissed
19 October 2018 - The High Court has dismissed the ACCC’s application to appeal a decision on whether Pfizer’s local ...
Posted by Michael Wonder on 19 Oct 2018
NICE rejects Lilly’s breast cancer drug Verzenios
19 October 2018 - As it stands Eli Lilly’s Verzenios will not be routinely funded on the NHS for breast ...
Posted by Michael Wonder on 18 Oct 2018
Northland mum Alethea Nathan with lung cancer pleads for publicly-funded medicine
19 October 2018 - Alethea Nathan has lung cancer, she is relying on her Life Insurance payout to cover the high ...
Posted by Michael Wonder on 18 Oct 2018
NHS green light for Novartis skin cancer combo
18 October 2018 - The NHS now has three months to ensure that Novartis’ combination therapy dabrafenib/trametinib is routinely available ...
Posted by Michael Wonder on 17 Oct 2018
Lojuxta to be reimbursed in France
17 October 2018 - Amryt's lead commercial product now available in all five of the EU's largest markets ...
Posted by Michael Wonder on 17 Oct 2018
Further hepatitis C drug delay 'cruel'
18 October 2018 - PHARMAC's decision to extend consultation on introducing new hepatitis C drugs is cruel and devastating for ...
Posted by Michael Wonder on 16 Oct 2018
Cystic fibrosis patients worry about future of 'life-changing' drug
16 October 2018 - A drug review body has recommended the drug not be covered by public benefit programs. ...
Posted by Michael Wonder on 16 Oct 2018
New checks to crack down on free prescription fraud
14 October 2018 - Patients claiming free prescriptions in England face checks before medicine is issued in an effort to ...
Posted by Michael Wonder on 16 Oct 2018
Model structuring for economic evaluations of new health technologies
17 October 2018 - In countries such as Australia, the UK and Canada, decisions on whether to fund new health technologies ...
Posted by Michael Wonder on 16 Oct 2018
Drug companies need to make costs more reasonable
16 October 2018 - Hundreds of women and their families marched on Parliament today to urge the funding of two ...
Posted by Michael Wonder on 16 Oct 2018
Breast cancer sufferers march on Parliament calling on PHARMAC to fund two 'game-changer' drugs
16 October 2018 - Women with breast cancer and their supporters marched to Parliament today calling for PHARMAC to fund ...